secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspire Biopharma Holdings, Inc. (ASBP)
CIK:        0001847345
Form:       8-K
Filed at:   2024-10-04T23:59:59+00:00
Accession:  0001493152-24-039574
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PowerUp Acquisition Corp. agrees to pay sponsor $1M fee upon closing of Aspire Biopharma deal
--------------------------------------------------------------------------------

- Sponsor SRIRAMA Associates to receive $1M modified promissory note fee upon successful closing of Aspire Biopharma business combination.
- Original $2M fee from terminated Visiox BCA replaced by this $1M fee.
- Fee included as Purchaser Expenses in the Aspire BCA dated August 26, 2024.
- Agreement dated October 2, 2024 between SPAC and Sponsor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224039574/0001493152-24-039574-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847345/000149315224039574/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039574

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer